文献速递疼痛医学神经外科与老年麻醉

小胶质细胞调控作为慢性疼痛治疗靶点:从实验室到临床再返回

Microglial Modulation as a Target for Chronic Pain: From the Bench to the Bedside and Back.
PubMed 文献 · Anesth Analg · 2019-01-01

本文综述慢性疼痛从神经元理论向神经元-胶质细胞相互作用理论的转变,重点讨论小胶质细胞作为损伤后神经免疫反应启动者在急性向慢性疼痛转换中的作用。文章总结临床前研究中通过药物和遗传调控小胶质细胞取得的显著成功及向临床领域的转化,并介绍利用正电子发射断层扫描(PET)在体内可视化胶质细胞激活、通过靶向18 kDa转位蛋白改善慢性疼痛诊断的最新努力。

要点

  • 小胶质细胞是损伤后神经免疫反应的启动者,参与急性向慢性疼痛的转换。
  • 临床前研究通过药物和遗传调控小胶质细胞已取得显著成功。
  • PET可视化胶质细胞激活及靶向18 kDa转位蛋白有望改善慢性疼痛诊断。

核心结论

  • 小胶质细胞参与损伤后神经免疫反应并促进急性向慢性疼痛转换,胶质靶向治疗时代正在开启。
  • 需在临床转化前以临床为导向优化临床前研究。

研究设计与样本

  • 综述,详细阐述慢性疼痛从神经元理论向包含复杂神经元-胶质细胞相互作用理论的转变。

主要发现

  • 小胶质细胞作为中枢神经系统髓系细胞,是损伤后神经免疫反应的启动者,参与急性向慢性疼痛转换。
  • 临床前研究通过药物和遗传调控小胶质细胞取得显著成功,并部分向临床领域转化。
  • 利用PET在体内可视化胶质细胞激活,通过放射性示踪剂结合小胶质细胞和髓系细胞中特定靶点如18 kDa转位蛋白,改善慢性疼痛诊断。

临床怎么用

  • 麻醉科医生作为围术期医师和疼痛医学专家,应关注小胶质细胞调控在慢性疼痛治疗中的潜在价值。
  • 关注PET可视化胶质细胞激活及靶向18 kDa转位蛋白在慢性疼痛诊断中的应用前景。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

With a widespread opioid epidemic and profound biopsychosocial implications, chronic pain is a multifaceted public health issue requiring urgent attention. The treatment of chronic pain is particularly important to anesthesiologists given our unique role as perioperative physicians and pain medicine specialists. The present review details the recent shift from a neuronal theory of chronic pain to one that includes complex neuron-glia interactions. In particular, we highlight microglia, the myeloid-lineage cells of the central nervous system, as initiators of a postinjury neuroimmune response that contributes to the acute to chronic pain transition. We discuss ever-advancing preclinical studies, wherein significant success has been made through pharmacologic and genetic modulation of microglia, and we emphasize where these approaches have made the transition to the clinical realm. Furthermore, we highlight the most current, novel efforts to visualize glial activation in vivo using positron emission tomography and improve the diagnosis of chronic pain through radiotracer binding of specific targets, like the 18 kDa translocator protein in microglia and myeloid-lineage cells. Our rapidly advancing knowledge about microglia and their involvement in pain suggests that the era of glial-targeted therapeutics is just beginning so long as we refocus our attention on optimizing preclinical studies using a clinically informed approach, before translation.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Haight ES, Forman TE, Cordonnier SA, et al. Microglial Modulation as a Target for Chronic Pain: From the Bench to the Bedside and Back. Anesth Analg. 2019. PMID: 30883419. doi:10.1213/ANE.0000000000004033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。